
Izvēlieties etiķeti
redzama tieši uz flakonaChonluten
Bioregulators
- Sūtām no Vācijas
Pasūtījums
- DHL ar izsekošanu
- Diskrēts iepakojums
Īsumā
Chonluten skaitļos
Galvenie rādītāji no mūsu leksikona.
Pilns leksikona ieraksts- Class
- Short bioregulator peptideKhavinson cytogen
- Use
- Subcutaneousin mg
- Sizes
- 20 mg1 size in the shop
What studies show
The source in the lexiconPeptides and aging: review of tissue-specific bioregulators (Khavinson program) (opens in a new tab)
Khavinson, Neuro Endocrinology Letters, 2002
Produktam Chonluten vēl nav laboratorijas analīzes. Balsot par toPasūtiet testu, mēs apmaksājam pusiVisas laboratorijas analīzes
Zināšanas
Viss par Chonluten
Detalizēta informācija drīzumā.
Dozēšana
Ielādē dozēšanas informāciju …
Noderēs
Kas jums vēl būs vajadzīgs
Bakteriostatiskais ūdens tiek automātiski pievienots grozam. Šļirces un salvetes - ar vienu klikšķi.
Insulīna šļirces
10 gab. · 5.50 €
Spirta salvetes
50 gab. · 10 €
Cik daudz ūdens?
Vienības uz šļirces jūsu flakona izmēram.
Atvērt kalkulatoru →Is Chonluten approved or studied in humans?
As of 26 October 2026 the registry ClinicalTrials.gov lists no trial with Chonluten. A review by the Khavinson group writes that EDG was given on top of usual care in chronic bronchitis and strengthened its effect. It gives no figures. This has not been checked independently.
What is Chonluten made of?
Of three amino acids: glutamic acid, aspartic acid and glycine, EDG for short, molecular formula C11H17N3O8. In older papers the same tripeptide is called T-34.
What did the study in immune cells show?
A group from Italy, together with the Khavinson group, tested five Khavinson peptides on a human monocyte cell line. After stimulation with bacterial components Chonluten dampened the release of TNF. All five peptides lowered TNF and IL-6 in mature macrophages and reduced their sticking to stimulated vessel wall. It was a cell culture without animals and without humans.
What is known about the stomach?
Under the code T-34 the tripeptide normalised the production of protective and inflammatory proteins in a model of stomach ulcers by influencing the related genes. A review by the group therefore also lists it as protection for the stomach.
How does Chonluten differ from Bronchogen?
According to the Khavinson group both target the airways. Chonluten is a tripeptide (EDG), Bronchogen a tetrapeptide (AEDL). For Bronchogen there is a rat model of COPD, for Chonluten mainly data from immune cells and the stomach.
How is such a short peptide supposed to work?
The Khavinson group assumes that short peptides reach the cell nucleus and influence genes. On the computer EDG fits well into the transporters PepT1 and LAT1 of the cell membrane. The group also suspects an effect against tumours through this. Whether this happens in the body has not been shown.
Which side effects are known?
There are no solid data because Chonluten has never been tested in a registered human trial. Statements about good tolerability come from the research group itself.
Saistītie
Saistītie produkti
Bronchogen
Peptīdi · Īpašie produkti un atbalsts Īpašie produkti un atbalsts
1 izmērs
= 32 €/flakons
Cardiogen
Peptīdi · Īpašie produkti un atbalsts Īpašie produkti un atbalsts
1 izmērs
= 32 €/flakons
Cortagen
Peptīdi · Īpašie produkti un atbalsts Īpašie produkti un atbalsts
1 izmērs
= 32 €/flakons
Crystagen
Peptīdi · Īpašie produkti un atbalsts Īpašie produkti un atbalsts
1 izmērs
= 32 €/flakons
Chonluten